Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: Analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)

Paul M. Ridker, Peter Libby, Jean G. MacFadyen, Tom Thuren, Christie Ballantyne, Francisco Fonseca, Wolfgang Koenig, Hiroaki Shimokawa, Brendan M. Everett, Robert J. Glynn

Research output: Contribution to journalArticlepeer-review

241 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: Analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)'. Together they form a unique fingerprint.

Medicine & Life Sciences